Samarium-153 Lexidronam for Painful Bone Metastases
Samarium-153 lexidronam (Quadramet - Dupont Pharma) has been approved by the FDA for relief of pain in patients with osteoblastic bone metastases. Strontium-89 (Metastron) has been available for several years for this indication (Medical Letter, 35:102, 1993)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Samarium-153 Lexidronam for Painful Bone Metastases
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1008
Article Code: 1008b
Date: August 29, 1997
Volume: 39
Pages: 83-84
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1008
Article Code: 1008b
Date: August 29, 1997
Volume: 39
Pages: 83-84
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)